Sleep Disorder (Sedative-Hypnotic) Drug Information
Sedative-hypnotic drug products are a class of drugs used to induce and/or maintain sleep.
FDA Drug Safety Communications:
- FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose (5/15/2014)
- FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR (5/14/2013)
- Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist) (1/10/2013)
Prescription Insomnia Drugs
For prescribing information, please search the Drugs@FDA
database.
- Ambien (zolpidem)
- Belsomra (suvorexant)
- Butisol (butabarbital)
- Doral (quazepam)
- Edluar (zolpidem)
- Estazolam
- Flurazepam
- Halcion (triazolam)
- Hetlioz (tasimelteon)
- Intermezzo (zolpidem)
- Lunesta (eszopiclone)
- Restoril (temazepam)
- Rozerem (ramelteon)
- Seconal (secobarbital)
- Silenor (doxepin)
- Sonata (zaleplon)
- Zolpimist (zolpidem)
Over-the-counter (OTC) Insomnia Drugs
*Also in many cold and headache combination products